Endocrinology

Latest News

FDA Faces Law Suit Over Sudden Removal of Tirzepatide from Drug Shortage List / image credit Mounjaro: ©MK Photo/stock.adobe.com
FDA Faces Law Suit Over Sudden Removal of Tirzepatide from Drug Shortage List

October 15th 2024

Update: The FDA has told compounding pharmacies they may resume production of tirzepatide products while the agency further investigates supply.

October Issue of Patient Care Online Supplement is Now Live
October Issue of Patient Care Online Supplement is Now Live

October 14th 2024

Sotagliflozin in Patients with Type 1 Diabetes and CKD to be Discussed at October FDA AdComm Meeting / image credit kidneys concept ©Rasi/stock.adobe.com
Sotagliflozin in Patients with Type 1 Diabetes and CKD to be Discussed at October FDA AdComm Meeting

October 14th 2024

Elinzanetant Update: FDA Accepts Bayer NDA, Sets July 2025 PDUFA Date / image credit FDA logo ©Araki Illustrations/stock.adobe.com
Elinzanetant Update: FDA Accepts Bayer NDA, Sets July 2025 PDUFA Date

October 11th 2024

Obesity Management Demands Much More than Medication / image credit - Livleen Gill,  MBA, RDN, LDN © Academy of Nutrition and Dietetics
Obesity Management Demands Much More than Medication

October 10th 2024

Latest CME Events & Activities

More News

© 2024 MJH Life Sciences

All rights reserved.